Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
NCT01289886 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2011-02-04
Summary
The objective of this study is to determine the safety and tolerability and to determine the Pharmacokinetic and Pharmacodynamic (PK/PD) of ascending single oral dose of BR-A-657 in healthy male subjects.
Conditions
- Essential Hypertension
Interventions
- DRUG
-
BR-A-657
20, 60, 120, 240, 360, 480mg or placebo tablet
Sponsors & Collaborators
-
Covance
collaborator INDUSTRY -
Boryung Pharmaceutical Co., Ltd
lead INDUSTRY
Principal Investigators
-
E Engmann, MB ChB · Covance Clinical Research Unit
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-09-30
- Primary Completion
- 2003-11-30
- Completion
- 2003-12-31
More Related Trials
-
A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
NCT00922441 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers
NCT01146938 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
NCT01148368 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension
NCT01672476 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
NCT02620306 ·Status: COMPLETED ·Phase: PHASE3
-
The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
NCT01135212 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan
NCT02147704 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
NCT05878561 ·Status: COMPLETED ·Phase: PHASE3
-
Fimasartan Achieving SBP Target (FAST) Study
NCT02495324 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
NCT01258673 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers
NCT03250052 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion
NCT02022774 ·Status: COMPLETED
-
A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension
NCT01878201 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers
NCT00938132 ·Status: COMPLETED ·Phase: PHASE1
-
Olmesartan Medoxomil Versus Losartan in Patients With Hypertension
NCT00857285 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension
NCT02248961 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
NCT01615198 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Fimasartan for Early Diastolic Heart Failure
NCT01691118 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)
NCT02394392 ·Status: COMPLETED
-
Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension
NCT00856271 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject
NCT02504606 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
NCT02222480 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment
NCT02448628 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan
NCT04991207 ·Status: COMPLETED ·Phase: PHASE1
-
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
NCT01609959 ·Status: COMPLETED ·Phase: PHASE4